Key facts
- Xenter’s last known valuation is $185.7M (Jan 2023).
- It has raised $32.7M across 3 recorded rounds; the latest was Seed Round ($1.1M) in Dec 2022.
- Notable investors include Black Mountain Investment Group, JAZ Capital Partners.
- Xenter has filed 4 Form Ds with the SEC since 2021, most recently Jan 2023 ($1.1M sold to 12 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Xenter
Funding rounds
3 roundsAbout Xenter
Developer of medical device technology designed to promote and optimize modern cardiac care. The company is engaged in the development of medical image management technology and software for neurological and cardiac disorders by leveraging principles of physical intelligence, enabling patients with invasive vascular and structural interventions.
- Sector
- Healthcare
- HQ
- Draper, UT, United States
- Founded
- 2020
- Employees
- 39
- Website
- xenter.io/
- Ownership
- Privately Held (backing)
Xenter doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Xenter shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Xenter in its N-PORT filings yet. We sweep new filings monthly.